NASDAQ:BMEA

Biomea Fusion Stock Predictions

Healthcare > Biotechnology

Buy BMEA

*Your capital is at risk

$1.30

-0.0700 (-5.11%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BMEA Prediction Chart

BMEA Predictions History

Latest community submissions for BMEA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	May 16, 2023	$33.34 -1.82%	$32.89	V	98.62%	2
jason.wilhidecomcast.361341	May 16, 2023	Bullish	$32.89	X	—	0
Skagitqg Merchant	Apr 12, 2023	Bearish	$25.02	V	—	1
PredictionBot.Kathy Pro	Mar 27, 2023	$14.93 -3.22%	$15.43	X	96.75%	0
PredictionBot.Warren Pro	Mar 27, 2023	$15.11 -2.01%	$15.43	X	97.96%	0
Skagitqg Merchant	Mar 27, 2023	Bullish	$15.43	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BMEA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIOMEA FUSION, INC.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by